|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.72 USD | -0.13% |
|
+0.25% | +58.82% |
| 05-26 | Eli Lilly to Acquire Three Vaccine Developers for Up to $3.83 Billion | MT |
| 05-20 | Eli Lilly Buys Engage Biologics for Up to $202 Million | DJ |
| Market Cap | 6.15B 5.31B 4.89B 4.58B 8.6B 584B 8.73B 58B 22.57B 284B 23.06B 22.57B 984B | P/E Ratio 2026 * |
-25.5x | P/E Ratio 2027 * | -22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.15B 5.31B 4.89B 4.58B 8.6B 584B 8.73B 58B 22.57B 284B 23.06B 22.57B 984B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 307x |
| Free-Float |
78.43% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.13% | ||
| 1 week | +0.25% | ||
| Current month | -0.10% | ||
| 1 month | +0.35% | ||
| 3 months | +50.85% | ||
| 6 months | +49.83% | ||
| Current year | +58.82% |
| 1 week | 39.58 |  | 39.83 |
| 1 month | 39.56 | | 39.98 |
| Current year | 21.5 | | 40.26 |
| 1 year | 12.05 | | 40.26 |
| 3 years | 4.75 | | 40.26 |
| 5 years | 2.88 | | 40.26 |
| 10 years | 2.88 | | 40.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 2025-12-31 | |
John Crowley
DFI | Director of Finance/CFO | 53 | 2024-06-09 |
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 2024-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | 2020-10-31 | |
Arjun Goyal
BRD | Director/Board Member | 45 | 2020-12-31 |
Brett Zbar
BRD | Director/Board Member | 53 | 2020-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 03-25 | Fiscal year | Head of Human Resources | 123,228 | 0.0922% | ||
| 03-25 | Fiscal year | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | +0.25% | +220.84% | +748.72% | 6.15B | |
| -0.35% | +0.97% | -15.96% | -12.73% | 43.03B | |
| +3.11% | +3.11% | +279.08% | +501.52% | 32.71B | |
| +0.22% | -1.08% | +15.66% | -15.65% | 30.29B | |
| +1.62% | -2.08% | -1.91% | +24.64% | 29.4B | |
| +4.09% | +0.93% | +10.83% | +18.78% | 25.08B | |
| -1.63% | +2.88% | +56.69% | +113.41% | 13.35B | |
| +1.14% | +3.62% | - | - | 13.54B | |
| -0.40% | -1.29% | +6.23% | +7.63% | 12.97B | |
| -0.74% | -1.62% | +105.89% | +74.92% | 12.11B | |
| Average | +0.69% | +1.33% | +75.26% | +162.36% | 21.86B | |
| Weighted average by Cap. | +1.02% | +1.45% | +61.49% | +115.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 20M 17.29M 15.93M 14.92M 27.98M 1.9B 28.4M 189M 73.44M 925M 75.06M 73.46M 3.2B |
| Net income | -243M -210M -194M -181M -340M -23.13B -345M -2.3B -893M -11.25B -913M -893M -38.96B | -262M -226M -209M -195M -366M -24.91B -372M -2.47B -962M -12.12B -983M -962M -41.95B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 39.72 $ | -0.13% | 1,322,753 |
| 26-06-11 | 39.77 $ | +0.20% | 871,057 |
| 26-06-10 | 39.69 $ | -0.18% | 1,780,789 |
| 26-06-09 | 39.76 $ | +0.15% | 2,302,698 |
| 26-06-08 | 39.70 $ | +0.20% | 553,287 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
